01 / Products
HEALIX Cast is an active clinical-stage device under FDA Breakthrough review. HEALIX Patch is a pre-clinical research system under active bench and animal-model investigation. Both run on the same IoT infrastructure and closed-loop architecture.
A next-generation orthopaedic cast that integrates twelve embedded biosensors with a closed-loop micro-needle analgesic delivery system modelled directly on insulin pump pharmacokinetics. Bone healing is monitored acoustically every 6 hours; the system autonomously adjusts analgesia to keep pain scores below 3/10 without clinician input. A dedicated dermis-care layer manages the skin environment under the cast: on-demand vibrotactile stimulation suppresses itch at source, while an encapsulated emollient micro-bead liner delivers hydration without cast removal.
1 MHz transducer array transmits through the cast shell, measuring acoustic impedance changes that correlate with callus density and mineralisation, calibrated against radiographic union staging.
280 μm hollow titanium micro-needles deliver NSAIDs, low-dose opioids, or ketamine subcutaneously. Dosing is computed by a PK/PD model that incorporates patient weight, pain NRS score, and cortisol proxy levels.
Continuous limb temperature mapping (16 thermal sensors) plus bioimpedance-derived pressure estimation. Alert fires when intracompartmental pressure exceeds 30 mmHg, giving a critical 4-hour advantage over clinical exam.
LSTM model trained on 52,000 longitudinal fracture cases produces a per-patient recovery roadmap: predicted soft-callus date, hard-callus date, and radiographic union, updated weekly with incoming sensor data.
Pulsed electromagnetic field coils (50 Hz, 1 mT) embedded in the cast shell deliver the FDA-cleared stimulation protocol automatically each night, and independent data shows 38% faster union time.
6-DOF inertial unit tracks joint angle, movement velocity, and symmetry during prescribed exercises. Haptic motor pulses provide real-time corrective cues; clinician receives weekly compliance and ROM reports.
Multi-frequency bioimpedance spectroscopy (5–500 kHz) quantifies extracellular fluid volume. Photoplethysmography array assesses limb perfusion index and detects DVT-suggestive waveform changes.
Two linear resonant actuators (LRAs) embedded in the inner shell deliver 80 Hz transcutaneous vibration bursts lasting 12 seconds. Stimulating fast-conducting Aβ nerve fibres via Gate Control Theory inhibits the itch signal from unmyelinated C fibres, verified against histamine-induced itch in Phase I skin studies. Patient-triggered via app or automated when a scratch-motion signature is detected by the IMU.
A thin hydrogel liner embedded with 150 μm phase-change wax microbeads carrying ceramide III, aloe barbadensis extract, and 5% urea. A resistive thin-film heater (37 °C, 200 mW) activates on demand through the patient app or on a scheduled 12-hour cycle, rupturing the bead shells and releasing emollient directly onto the skin surface without cast removal. Each cartridge provides a 7-day moisture supply.
Qi-compatible inductive coil charges the 300 mAh LiPo pack through the TPU shell. The battery achieves a 7-day life and charges fully in 90 minutes. Drug cartridge hot-swappable via magnetic latch without cast removal.
A pre-clinical smart wound monitoring system designed to detect early indicators of surgical site infection using continuous sensing and predictive analytics. The project investigates how compact, wearable hardware can support proactive post-operative care while minimising interference with the wound healing environment.
Electrochemical nanosensor array measures IL-6, CRP, procalcitonin, and lactate in wound exudate every 30 min, providing a localised infection signature hours before systemic signs emerge.
On-device LSTM model analyses multi-biomarker trajectories to generate an SSI risk score, distinguishing normal post-surgical inflammation from early infectious escalation with 91% sensitivity.
Hydrogel micro-reservoir delivers topical antibiotics directly to the wound bed when the SSI risk score crosses a validated threshold, interrupting infection before systemic escalation.
A 3×3 spatial pH sensor grid maps localised acidification (indicative of anaerobic bacteria), while impedance-based moisture sensors maintain the optimal healing microenvironment.
Aptamer-functionalised electrodes discriminate between MRSA, E. coli, Pseudomonas aeruginosa, and Enterococcus, enabling targeted rather than empirical antibiotic selection.
Ultra-flexible PDMS substrate conforms to wound contours without adhesive trauma. Wireless power and data via NFC eliminate cable disruption during dressing changes.
Microfluidic channels continuously sample wound fluid for MMP-2, MMP-9, and elastase, which are key markers distinguishing acute healing from chronic wound stagnation.
Three-level alert system: local auto-dose at level 1, mobile notification to nursing staff at level 2, and direct physician page with AI-generated triage summary at level 3.